Penumbra Inc (PEN) stock
PENNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/3074% above fair value
$320.60+1.49 (+0.47%)
Close on Nov 18, 2026Market cap $12.64BP/E 80.8Yield –
Penumbra free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Penumbra's free cash flow for the twelve months ending Sep 30, 2026 was $200.29M, up 31.2% year over year. For fiscal 2025 it was $174.93M, up 18.8% from the year before. The highest annual figure on record is $174.93M in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $174.93M | +18.8% |
| FY2024 | Dec 31, 2024 | $147.30M | +79.4% |
| FY2023 | Dec 31, 2023 | $82.12M | – |
| FY2022 | Dec 31, 2022 | -$74.96M | – |
| FY2021 | Dec 31, 2021 | -$11.68M | – |
| FY2020 | Dec 31, 2020 | -$58.00M | -1376.6% |
| FY2019 | Dec 31, 2019 | $4.54M | -76.3% |
| FY2018 | Dec 31, 2018 | $19.21M | +11978.6% |
| FY2017 | Dec 31, 2017 | $159.00K | – |
| FY2016 | Dec 31, 2016 | -$26.44M | – |
| FY2015 | Dec 31, 2015 | -$26.16M | – |
| FY2014 | Dec 31, 2014 | -$10.28M | – |
| FY2013 | Dec 31, 2013 | -$4.19M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $26.40M | -37.2% |
| Q2 FY2026 | Jun 30, 2026 | $32.54M | +10.8% |
| Q1 FY2026 | Mar 31, 2026 | $73.30M | +106.5% |
| Q4 FY2025 | Dec 31, 2025 | $68.05M | +48.8% |
| Q3 FY2025 | Sep 30, 2025 | $42.01M | -17.6% |
| Q2 FY2025 | Jun 30, 2025 | $29.37M | +62.5% |
| Q1 FY2025 | Mar 31, 2025 | $35.50M | +9.3% |
| Q4 FY2024 | Dec 31, 2024 | $45.74M | +40.2% |
| Q3 FY2024 | Sep 30, 2024 | $51.02M | +85.4% |
| Q2 FY2024 | Jun 30, 2024 | $18.08M | +41.7% |
| Q1 FY2024 | Mar 31, 2024 | $32.47M | +251.6% |
| Q4 FY2023 | Dec 31, 2023 | $32.62M | – |
| Q3 FY2023 | Sep 30, 2023 | $27.51M | – |
| Q2 FY2023 | Jun 30, 2023 | $12.76M | – |
| Q1 FY2023 | Mar 31, 2023 | $9.24M | – |
| Q4 FY2022 | Dec 31, 2022 | -$2.23M | – |
| Q3 FY2022 | Sep 30, 2022 | -$19.26M | -162.8% |
| Q2 FY2022 | Jun 30, 2022 | -$44.01M | – |
| Q1 FY2022 | Mar 31, 2022 | -$9.47M | – |
| Q4 FY2021 | Dec 31, 2021 | -$17.36M | – |
| Q3 FY2021 | Sep 30, 2021 | $30.65M | – |
| Q2 FY2021 | Jun 30, 2021 | -$6.61M | – |
| Q1 FY2021 | Mar 31, 2021 | -$18.36M | – |
| Q4 FY2020 | Dec 31, 2020 | -$5.84M | – |
| Q3 FY2020 | Sep 30, 2020 | -$7.70M | -154.5% |
| Q2 FY2020 | Jun 30, 2020 | -$28.41M | – |
| Q1 FY2020 | Mar 31, 2020 | -$16.05M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.22M | -171.6% |
| Q3 FY2019 | Sep 30, 2019 | $14.13M | +57.3% |
| Q2 FY2019 | Jun 30, 2019 | -$1.84M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.53M | -157.5% |
| Q4 FY2018 | Dec 31, 2018 | $4.49M | – |
| Q3 FY2018 | Sep 30, 2018 | $8.99M | -3.5% |
| Q2 FY2018 | Jun 30, 2018 | -$2.16M | – |
| Q1 FY2018 | Mar 31, 2018 | $7.89M | – |
| Q4 FY2017 | Dec 31, 2017 | -$6.63M | – |
| Q3 FY2017 | Sep 30, 2017 | $9.31M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.52M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.00M | – |
| Q4 FY2016 | Dec 31, 2016 | -$16.91M | – |
See a number that looks wrong?